Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation
Acrux Ltd (ASX:ACR) has been approved to begin U.S. commercialisation activities for…
Acrux Limited (ASX:ACR)
About Acrux Limited
Key Information
ACR In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 19/12/2024 | Change in substantial holding | 91.7KB | 305 |
| 19/12/2024 | Cleansing Notice | 131.94KB | 128 |
| 19/12/2024 | Application for quotation of securities - ACR | 15.67KB | 126 |
| 17/12/2024 | Price Sensitive PS Investor Deck update, SPP Closes 18 December 2024, 5pm | 1.94MB | 456 |
| 16/12/2024 | Investor Webinar, Tuesday 17 December 2024 4pm AEDT | 121.92KB | 236 |
| 13/12/2024 | Price Sensitive PS Commercialisation of Nitroglycerin Ointment | 153.62KB | 862 |
| 12/12/2024 | Cleansing Notice | 133.14KB | 169 |
| 12/12/2024 | Application for quotation of securities - ACR | 15.61KB | 183 |